FDA Approves Oral Antiviral to Prevent COVID-19 After Exposure

(MedPage Today) -- The FDA approved the oral antiviral agent ensitrelvir (Xocova) to help prevent COVID-19 in people ages 12 years or older who were exposed to the SARS-CoV-2 virus, drugmaker Shionogi announced. Ensitrelvir is a SARS-CoV-2 main...
Source
MedPage Today
Opens original article in a new tab



